Bandaram Pharma Packtech Limited - manufacturing in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN L93090KA1993PLC159827 Incorporated 05 August 1993 ROC Bangalore HQ Bangalore, Karnataka, India
Active Listed - BSE: 524602 Public Limited Company manufacturing
Market Cap
₹32.94 Cr
BANDARAM · BSE
Share Price
₹18.59
+1.42% today
Revenue
₹62.92 Cr
FY 2025-26 · +70.2% YoY
EBITDA
₹2.90 Cr
Margin 4.6%
Net Profit
₹0.45 Cr
FY 2025-26 · -54.1% YoY
P/E (TTM)
132.4x
P/B 1.2x
ROE
1.4%
ROCE 4.8%
Debt / Equity
1.04
Interest cover 78.2x

About Bandaram Pharma Packtech Limited

Data last updated:

Bandaram Pharma Packtech Limited is a public limited company based in Bangalore, Karnataka, India. It operates in the paper and packaging products segment of the manufacturing sector. It was incorporated on 05 August 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN L93090KA1993PLC159827. Its GSTIN is 29AAACS0289E1ZD (Karnataka). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524602.

The company has an authorised share capital of ₹19 Cr and a paid-up capital of ₹17.97 Cr. It is led by directors including Deepak Bandaram (Managing Director) and Bhandaram Sathyavathi.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 601 5th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹62.92 Cr, a growth of 70.2% compared to the previous year. For the same year it recorded a net profit of ₹45 Lakh (net margin 0.7%) and EBITDA of ₹2.9 Cr (EBITDA margin 4.6%). The net worth stands at ₹26.78 Cr (up 111.7% YoY). Total assets are valued at ₹55.31 Cr (up 67.7% YoY).

The company is associated with 2 brands: Shiva Medicare and Bandaram Pharma Packtech. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹18.42 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 1 deal on record (1 acquisition); the latest was in March 2016.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivamedicare.com.

Company details

CIN L93090KA1993PLC159827
Registration Number 159827
Incorporation Date 05 August 1993
ROC Bangalore
Listing Status Listed - Listed on BSE (524602)
Company Status Active
Compliance Status Active Compliant

CIN history

Bandaram Pharma Packtech has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L93090KA1993PLC159827, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L93090KA1993PLC159827Current
L93090TG1993PLC088165Previous
L93090DL1993PLC186295Previous
L93090TN1993PLC025563Previous
L93090AP1993PLC088165Previous

Contact details

Bandaram Pharma Packtech Limited's registered office is in Bangalore, Karnataka. Its website is shivamedicare.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    601 5th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008
  • Industry
    Manufacturing, Paper & Packaging Products

To see the full contact details of Bandaram Pharma Packtech Limited, buy the company report.

Comprehensive company report
Bandaram Pharma Packtech Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Bandaram Pharma Packtech operates two associated brands: Shiva Medicare and Bandaram Pharma Packtech. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of auto retractable safety syringeshivamedicare.com
Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech.bandaram.com

Financials of Bandaram Pharma Packtech Limited

FY 2025-26 filings available

Bandaram Pharma Packtech Limited reported revenue of ₹62.92 Cr (up 70.2% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹62.92 Cr
+70.2% YoY
EBITDA
₹2.90 Cr
+3.2% YoY
Profit After Tax
₹0.45 Cr
-54.1% YoY
Net Worth
₹26.78 Cr
+111.7% YoY
Total Assets
₹55.31 Cr
+67.7% YoY
Total Debt
₹23.95 Cr
+39.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue62.9236.9634.0818.73
Revenue growth+70.2%+8.5%+82.0%-
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Profit before tax0.441.301.190.32
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
Balance sheet
Total assets55.3132.9827.2719.34
Net worth26.7812.6512.283.08
Total debt23.9517.1512.2014.20
Cash & bank0.720.120.040.16
Net working capital36.5625.0221.3514.27
Cash flow
Cash from operations(4.92)(4.93)(4.13)(1.10)
Cash from investing0.00(0.08)(1.58)(5.30)
Cash from financing5.535.095.594.47
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue21.4523.9526.2614.8413.728.108.4910.00
Revenue growth (YoY)+56.3%+195.7%+209.3%+48.4%+93.0%-28.8%--
Other income0.000.000.010.000.010.000.090.00
EBITDA1.161.540.821.000.450.630.540.66
EBITDA margin+5.4%+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%
Depreciation0.250.200.250.140.140.130.530.15
Interest0.480.420.460.330.250.46(0.10)0.24
Profit before tax0.430.920.120.530.070.040.200.27
Tax0.240.240.030.180.020.010.050.28
Net profit0.190.680.090.350.050.030.15(0.01)
EPS (₹)(0.12)0.110.050.110.030.020.13(0.01)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Income statement
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-10.4%-17.6%+47.1%----
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
Balance sheet
Total assets27.4015.5912.227.482.990.100.39
Net worth22.8812.1012.203.072.99(2.32)(1.78)
Total debt4.513.490.024.410.001.451.20
Cash & bank0.260.020.040.092.080.000.00
Net working capital5.506.498.304.952.99(0.39)(0.18)
Cash flow
Cash from operations1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Cash from investing(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Cash from financing1.033.234.614.400.720.000.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2.372.998.201.680.330.763.712.63
Revenue growth (YoY)+618.2%+293.4%+121.0%-36.1%-89.6%-72.1%--
Other income0.000.000.000.000.010.000.090.00
Total expenses2.783.348.531.890.681.033.752.58
EBITDA(0.41)(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.05
EBITDA margin-17.3%-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.41)(0.35)(0.33)(0.21)(0.34)(0.27)0.050.05
Tax0.000.000.000.000.000.000.010.03

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 18 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue21.4523.9526.2614.8413.728.108.4910.00
Revenue growth (YoY)+56.3%+195.7%+209.3%+48.4%+93.0%-28.8%--
Other income0.000.000.010.000.010.000.090.00
EBITDA1.161.540.821.000.450.630.540.66
EBITDA margin+5.4%+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%
Depreciation0.250.200.250.140.140.130.530.15
Interest0.480.420.460.330.250.46(0.10)0.24
Profit before tax0.430.920.120.530.070.040.200.27
Tax0.240.240.030.180.020.010.050.28
Net profit0.190.680.090.350.050.030.15(0.01)
EPS (₹)(0.12)0.110.050.110.030.020.13(0.01)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Revenue62.9236.9634.0818.73
Revenue growth+70.2%+8.5%+82.0%-
Other income0.020.090.030.19
Total expenses60.0234.1531.2617.58
Employee cost0.002.962.330.64
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Depreciation0.970.610.730.59
Interest1.510.990.930.43
Profit before tax0.441.301.190.32
Tax(0.01)0.320.240.07
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital17.9712.0012.003.00
Reserves & surplus8.810.650.280.08
Shareholders' funds (net worth)26.7812.6512.283.08
Minority interest4.583.172.792.05
Secured loans14.9210.521.781.97
Unsecured loans9.036.6310.4212.23
Total debt23.9517.1512.2014.20
Total liabilities55.3132.9827.2719.34
Assets
Gross block15.223.955.915.03
Net block15.223.954.485.03
Capital work in progress0.000.000.000.00
Investments0.001.401.400.00
Inventories12.948.516.472.71
Sundry debtors31.3518.7614.526.62
Cash & bank balances0.720.120.040.16
Loans & advances11.983.505.035.57
Total current assets56.9930.8926.0615.06
Total current liabilities20.435.874.710.79
Net working capital36.5625.0221.3514.27
Total assets55.3132.9827.2719.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Opening cash0.120.040.162.09
Net cash from operating activities(4.92)(4.93)(4.13)(1.10)
Net cash from investing activities0.00(0.08)(1.58)(5.30)
Net cash from financing activities5.535.095.594.47
Net change in cash0.600.08(0.11)(1.93)
Closing cash0.720.120.040.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth+70.2%+8.5%+82.0%-
EBITDA growth+3.2%-0.4%+145.2%-
PBT growth-66.2%+9.2%+271.9%+9997.0%
Net income growth-54.1%+3.2%+630.8%-
Revenue CAGR (3Y)+49.8%---
EBITDA CAGR (3Y)+36.1%---
Profitability & leverage
Net income margin+0.5%+2.7%+2.8%+1.3%
Return on capital employed+4.8%+8.5%+10.2%+4.4%
Return on net worth+1.4%+7.9%+12.4%+8.4%
Debt / equity1.041.181.724.61
Long-term debt / equity0.480.550.802.48
Interest cover78.2445.0044.5076.79
Efficiency & per share
Fixed asset turnover6.567.506.233.72
Inventory turnover5.874.937.426.91
Debtors turnover2.512.223.222.83
EPS (₹)0.160.830.790.47
Dividend per share (₹)0.000.100.100.10
Book value per share (₹)14.9010.5410.2310.28
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2.372.998.201.680.330.763.712.63
Revenue growth (YoY)+618.2%+293.4%+121.0%-36.1%-89.6%-72.1%--
Other income0.000.000.000.000.010.000.090.00
Total expenses2.783.348.531.890.681.033.752.58
EBITDA(0.41)(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.05
EBITDA margin-17.3%-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.41)(0.35)(0.33)(0.21)(0.34)(0.27)0.050.05
Tax0.000.000.000.000.000.000.010.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-10.4%-17.6%+47.1%----
Other income0.010.090.030.000.000.000.00
Total expenses12.1312.1414.689.820.010.011.12
Employee cost0.001.101.140.080.000.000.37
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Depreciation0.000.010.020.000.000.020.03
Interest0.000.000.000.000.000.000.01
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Tax0.000.050.040.070.000.000.00
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Equity & liabilities
Share capital17.9712.0012.003.003.002.282.28
Reserves & surplus4.910.100.200.07(0.01)(4.60)(4.06)
Shareholders' funds (net worth)22.8812.1012.203.072.99(2.32)(1.78)
Secured loans0.000.000.000.000.000.000.00
Unsecured loans4.513.490.024.410.001.451.20
Total debt4.513.490.024.410.001.451.20
Total liabilities27.4015.5912.227.482.990.100.39
Assets
Gross block0.030.030.030.030.000.110.21
Net block0.010.010.010.030.000.110.18
Capital work in progress0.000.000.000.000.000.000.00
Investments17.853.913.912.510.000.000.00
Inventories2.081.642.160.550.000.000.00
Sundry debtors10.676.622.402.690.000.000.00
Cash & bank balances0.260.020.040.092.080.000.00
Loans & advances1.701.844.832.410.920.770.77
Total current assets14.7110.129.435.743.000.770.77
Total current liabilities9.213.631.130.790.011.160.95
Net working capital5.506.498.304.952.99(0.39)(0.18)
Total assets27.4015.5912.227.482.990.100.39
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Opening cash0.020.040.092.080.000.000.57
Net cash from operating activities1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Net cash from investing activities(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Net cash from financing activities1.033.234.614.400.720.000.00
Net change in cash0.24(0.02)(0.04)(2.00)2.080.00(0.56)
Closing cash0.260.020.040.092.080.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Growth
Sales growth-10.4%-17.6%+47.1%----
EBITDA growth-1400.0%-43.8%-40.7%+2800.0%0.0%--
PBT growth-0.0%-37.0%+9998.0%+66.7%+97.4%-6.4%
Net income growth-1066.7%-7.7%-35.0%+2100.0%+66.7%--
Revenue CAGR (3Y)+2.8%------
EBITDA CAGR (3Y)-----79.1%-41.5%+382.0%
Profitability & leverage
Net income margin-10.6%+1.0%+0.9%+2.0%---
Return on capital employed0.0%+1.4%+1.7%+5.2%0.0%0.0%0.0%
Return on net worth0.0%+1.2%+1.7%+6.6%0.0%0.0%0.0%
Debt / equity0.230.140.290.732.170.000.00
Long-term debt / equity0.230.140.290.732.170.000.00
Interest cover0.000.000.000.000.000.00-0.87
Efficiency & per share
Fixed asset turnover365.33407.67494.67672.670.000.000.00
Inventory turnover5.896.4410.9536.690.000.000.00
Debtors turnover1.272.715.837.500.000.000.00
EPS (₹)(0.65)0.120.110.68(0.03)(0.14)0.00
Dividend per share (₹)0.000.100.100.100.000.000.00
Book value per share (₹)12.7310.0910.1710.259.97(10.18)(7.82)

To see the full year-wise statements and ratios of Bandaram Pharma Packtech Limited, buy the company report.

Board of directors of Bandaram Pharma Packtech Limited

Bandaram Pharma Packtech has 7 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhandaram SathyavathiDirector07 Mar 20224 Years 8 MonthsCurrent
Bhandaram Premsai ReddyDirector07 Mar 20224 Years 8 MonthsCurrent
Suryaprakasa Rao BommisettiDirector07 Mar 20224 Years 8 MonthsCurrent
Deepak BandaramManaging Director07 Feb 20233 Years 9 MonthsCurrent
Mounika PammiDirector20 Jun 20251 Years 4 MonthsCurrent
Suman MalluDirector01 Sep 20233 Years 2 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Auditor

Bandaram Pharma Packtech Limited is audited by M M REDDY & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M M REDDY & COFY 2023010371S

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 62.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 37.30%.

Promoters: 62.70%Retail & Others: 37.30%
Sep 2026
QUARTER
62.70% Promoters
37.30% Retail & Others
Promoter holding - history
Now 62.70% · Sep 2026High 75.00% · Dec 2025Low 62.60% · Mar 2026
61%64.8%68.5%72.3%76%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 75.00%Mar 2026: 62.60%Jun 2026: 62.70%Sep 2026: 62.70%75.00%62.60%62.70%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters62.70%62.70%62.60%75.00%
Public37.30%37.30%37.40%25.00%

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
₹18.42 Cr
Breakdown by lending institutions
State Bank of India;₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 May 199290304641State Bank of India;₹25 LakhOpen
30 May 199290307340State Bank of India;₹25 LakhOpen
18 Jan 2024100856382Others₹10 CrSatisfied
16 Jun 199890305176State Bank of India;₹7 CrSatisfied
30 Apr 199690307610Union Bank of India₹1.42 CrSatisfied

To see the full charge records of Bandaram Pharma Packtech Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Bandaram Pharma Packtech Limited has 1 deal on record (1 acquisition); the latest was in March 2016.

Total deals
1
Acquisition
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2016Acquisition₹2.26 CrBuyer: Grey Mat Techno Solutions Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bandaram Pharma Packtech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bandaram Pharma Packtech has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
29AAACS0289E1ZDKarnatakaActive14 Sep 2022

To see the full GST registrations and return filing status of Bandaram Pharma Packtech Limited, buy the company report.

Recent activity

Bandaram Pharma Packtech Limited has 52 board changes on record since 2005: 32 appointments and 20 cessations. The latest: Eswar Reddy Putturu was appointed as Director on 30 Jan 2026.

Filing
Bandaram Pharma Packtech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Bangalore.
Appointed
Eswar Reddy Putturu was appointed as Director.
Charges
A charge registered on 18 Jan 2024 via Charge ID 100856382 with Others was fully satisfied on 23 Dec 2025.
AGM
Bandaram Pharma Packtech Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Mounika Pammi was appointed as Director.
Ceased
Venkata Subramanya Rajaram Chittuluru ceased to be Director.
Appointed
Nadella Srinivasula Kalki Aakarsh Raj was appointed as Whole-Time Director.
Ceased
Bhandaram Munirathnam Muniratnam Reddy ceased to be Director.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100856382 was registered on 18 Jan 2024.
Appointed
Priyanka Agarwal was appointed as Director.
Appointed
Kankariya Neha was appointed as Company Secretary.
Appointed
Suman Mallu was appointed as Director.

54 earlier events are in the company report.

Frequently asked questions

Bandaram Pharma Packtech is an active public limited company based in Bangalore, Karnataka, India. The company works in paper and packaging products, within the manufacturing industry. It was incorporated on 05 August 1993 (33+ years old) and is registered under CIN L93090KA1993PLC159827. Listed on BSE: 524602.

Bandaram Pharma Packtech reported revenue of ₹62.92 Cr for FY 2025-26 (up 70.2% YoY) based on consolidated financials.

Bandaram Pharma Packtech has 7 current directors:

The latest financial statements of Bandaram Pharma Packtech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bandaram Pharma Packtech is 29AAACS0289E1ZD, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Bandaram Pharma Packtech is L93090KA1993PLC159827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Bandaram Pharma Packtech is a listed company as per MCA records. Its shares are listed on BSE (code: 524602).

Bandaram Pharma Packtech has 1 court case on record: 1 filed against it. 1 is pending.

Bandaram Pharma Packtech was incorporated on 05 August 1993, making it 33+ years old. It is registered with the Registrar of Companies, Bangalore.

Bandaram Pharma Packtech has 1 deal on record (1 acquisition); the latest was in March 2016.